Terrence Higgins Trust uses cookies to improve your experience of our websites. For more information or to change the use of cookies, please click here.

Accept and Close

Truvada (emtricitabine + tenofovir disoproxil)

Truvada

Generic name: emtricitabine (also known as FTC) and tenofovir disoproxil

Brand names: Truvada

Class: Combined NRTI (nukes) tablets

Side-effects:

For emtricitabine:


Common: nausea, diarrhoea, headache, raised kinase levels which can cause muscle pain and weakness, skin darkening especially in children, difficulty sleeping, abnormal dreams, dizziness, vomiting, stomach pain, rash, pain.


Rare: anaemia, swelling of the face, lips, tongue or throat.


For tenofovir disoproxil:


Common: Nausea, vomiting, diarrhoea, dizziness, low blood phosphate levels, weakness, rash, headache, stomach pains, fatigue, bloating, flatulence, liver problems.


Rare: Kidney problems, bone thinning, lactic acidosis, pancreatitis, lipodystrophy.

Dosage:

Tablet comprises 200mg emtricitabine and 245mg tenofovir disoproxil.

Take one tablet once a day.

Notes:

Take with food.


*Last reviewed on 23/09/2015 Next review: 23/09/2018

Any questions? Email feedback@tht.org.uk Information included on this website was correct at the time of publication.

Data and image supplied by NAM.

Further information on this drug from NAM